富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/08/27 | 日証協 | 61,862株 | -2.3% | 16,500株 | +36% | 203,519株 | -3.89% | 27,594株 | +7.81% |
2021/08/20 | 日証協 | 63,321株 | +3.42% | 12,132株 | -18.45% | 211,762株 | +1.78% | 25,595株 | -21.64% |
2021/08/13 | 日証協 | 61,225株 | -2.88% | 14,876株 | -62.53% | 208,062株 | -2.1% | 32,662株 | -27.54% |
2021/08/06 | 日証協 | 63,039株 | +1.94% | 39,697株 | +47.57% | 212,534株 | -3.84% | 45,073株 | +11.07% |
2021/07/30 | 日証協 | 61,837株 | +6% | 26,900株 | +35.09% | 221,011株 | -3.3% | 40,582株 | +14.25% |
2021/07/21 | 日証協 | 58,338株 | +17.44% | 19,913株 | +15.77% | 228,557株 | -3.33% | 35,520株 | +14.97% |
2021/07/16 | 日証協 | 49,673株 | -11.02% | 17,200株 | -7.21% | 236,431株 | +1.37% | 30,896株 | -33.54% |
2021/07/09 | 日証協 | 55,827株 | -5.58% | 18,537株 | -33.58% | 233,231株 | -0.21% | 46,491株 | +64.87% |
2021/07/02 | 日証協 | 59,127株 | +23.82% | 27,910株 | +33.57% | 233,731株 | +6.96% | 28,199株 | -74.03% |
2021/06/25 | 日証協 | 47,754株 | -26.57% | 20,895株 | +1.43% | 218,531株 | +2.29% | 108,603株 | +405.18% |
2021/06/18 | 日証協 | 65,034株 | +23.32% | 20,600株 | +472.22% | 213,631株 | +3.74% | 21,498株 | +40.27% |
2021/06/11 | 日証協 | 52,734株 | -49.98% | 3,600株 | -94.04% | 205,931株 | -12.63% | 15,326株 | -63.34% |
2021/06/04 | 日証協 | 105,434株 | -32.2% | 60,383株 | -50.38% | 235,705株 | -5.56% | 41,811株 | -70.49% |
2021/05/28 | 日証協 | 155,504株 | +117.78% | 121,700株 | +72.14% | 249,594株 | +0.89% | 141,700株 | +279.89% |
2021/05/21 | 日証協 | 71,404株 | -17.55% | 70,700株 | +4.74% | 247,394株 | +13.33% | 37,300株 | -37.63% |
2021/05/14 | 日証協 | 86,604株 | +67.99% | 67,500株 | +88.11% | 218,294株 | +31.48% | 59,800株 | +382.26% |
2021/05/07 | 日証協 | 51,554株 | -16.92% | 35,883株 | +29.54% | 166,028株 | -10.17% | 12,400株 | -65.27% |
2021/04/30 | 日証協 | 62,054株 | +1.64% | 27,700株 | -57.57% | 184,828株 | +10.46% | 35,700株 | +134.47% |
2021/04/23 | 日証協 | 61,054株 | +47.22% | 65,283株 | +82.87% | 167,328株 | -2.69% | 15,226株 | -33.9% |
※株式分割は考慮していませんのでご注意ください。
Page Top